Immunome, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 11/13/2025 | 13.06 M | $152.89 M | 111.70% | 15.01% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2025 | 8.42 M | $98.58 M | 1.73% | 9.67% |
| BLACKROCK, INC. | 11/12/2025 | 5.82 M | $68.18 M | 0.90% | 6.69% |
| REDMILE GROUP, LLC | 11/14/2025 | 5.02 M | $58.82 M | 3.10% | 5.77% |
| VANGUARD GROUP INC | 11/07/2025 | 4.89 M | $57.30 M | 8.15% | 5.62% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 4.82 M | $56.49 M | 2.96% | 5.54% |
| ENAVATE SCIENCES GP, LLC | 11/14/2025 | 4.77 M | $55.84 M | 0.00% | 5.48% |
| ECOR1 CAPITAL, LLC | 11/14/2025 | 4.08 M | $47.77 M | 0.00% | 4.69% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 3.74 M | $43.83 M | 25.51% | 4.30% |
| OPALEYE MANAGEMENT INC. | 11/14/2025 | 3.19 M | $37.30 M | -9.76% | 3.66% |
| PRIMECAP MANAGEMENT CO/CA/ | 11/12/2025 | 3.02 M | $35.34 M | -0.07% | 3.47% |
| STATE STREET CORP | 11/14/2025 | 2.80 M | $32.83 M | 11.23% | 3.22% |
| JEFFERIES FINANCIAL GROUP INC. | 11/13/2025 | 2.10 M | $24.59 M | 0.69% | 2.41% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.89 M | $22.19 M | 1.83% | 2.18% |
| MORGAN STANLEY | 11/14/2025 | 1.83 M | $21.47 M | 353.51% | 2.11% |
| READYSTATE ASSET MANAGEMENT LP | 11/07/2025 | 1.32 M | $15.44 M | -2.61% | 1.52% |
| WOODLINE PARTNERS LP | 11/14/2025 | 1.27 M | $14.93 M | -23.15% | 1.47% |
| PRINCIPAL FINANCIAL GROUP INC | 11/04/2025 | 1.10 M | $12.94 M | 222.34% | 1.27% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2025 | 1.06 M | $12.40 M | 5.88% | 1.22% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 1.04 M | $12.19 M | 100.00% | 1.20% |
| TORONTO DOMINION BANK | 11/14/2025 | 1.04 M | $12.13 M | -50.33% | 1.19% |
| TORONTO DOMINION BANK | 11/14/2025 | 1.04 M | $12.13 M | -50.34% | 1.19% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 1.04 M | $12.13 M | 100.00% | 1.19% |
| CANDRIAM S.C.A. | 11/06/2025 | 859.53 K | $10.07 M | 170.22% | 0.99% |
| CITADEL ADVISORS LLC | 11/14/2025 | 841.14 K | $9.85 M | 100.00% | 0.97% |
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 763.18 K | $8.94 M | -26.65% | 0.88% |
| NORTHERN TRUST CORP | 11/14/2025 | 706.52 K | $8.27 M | 2.16% | 0.81% |
| TD ASSET MANAGEMENT INC | 11/10/2025 | 701.28 K | $8.21 M | 15.81% | 0.81% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2025 | 696.55 K | $8.16 M | 215.18% | 0.80% |
| MARSHALL WACE, LLP | 11/13/2025 | 692.18 K | $8.11 M | -46.66% | 0.80% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 663.61 K | $7.77 M | 3.65% | 0.76% |
| NAN FUNG TRINITY (HK) LTD | 11/04/2025 | 592.10 K | $6.93 M | 7.88% | 0.68% |
| UBS GROUP AG | 11/13/2025 | 583.94 K | $6.84 M | 37.10% | 0.67% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 11/13/2025 | 502.51 K | $5.88 M | 100.00% | 0.58% |
| SOFINNOVA INVESTMENTS, INC. | 11/14/2025 | 436.05 K | $5.11 M | -43.99% | 0.50% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 11/14/2025 | 426.22 K | $4.99 M | 8.52% | 0.49% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2025 | 351.13 K | $4.11 M | 100.00% | 0.40% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 338.36 K | $3.96 M | 222.91% | 0.39% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11/14/2025 | 290.44 K | $3.40 M | 3.43% | 0.33% |
| KENNEDY CAPITAL MANAGEMENT LLC | 11/13/2025 | 257.43 K | $3.01 M | 135.41% | 0.30% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 254.07 K | $2.98 M | 19.94% | 0.29% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 217.04 K | $2.54 M | 5.74% | 0.25% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 208.95 K | $2.45 M | -56.34% | 0.24% |
| BARCLAYS PLC | 11/12/2025 | 208.51 K | $2.44 M | -9.29% | 0.24% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 202.30 K | $2.37 M | 103.58% | 0.23% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 195.80 K | $2.29 M | 740.34% | 0.23% |
| AXA INVESTMENT MANAGERS S.A. | 11/14/2025 | 180.06 K | $2.11 M | 100.00% | 0.21% |
| HANDELSBANKEN FONDER AB | 11/12/2025 | 180.00 K | $2.11 M | -10.00% | 0.21% |
| NEOS INVESTMENT MANAGEMENT LLC | 11/07/2025 | 162.19 K | $1.90 M | 40.50% | 0.19% |
| TEMA ETFS LLC | 10/24/2025 | 162.19 K | $1.90 M | 40.50% | 0.19% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Immunome, Inc. institutional Ownership - FAQ's
During the previous two years, 179 institutional investors and hedge funds held shares of Immunome, Inc.. The most heavily invested institutionals were:
FMR LLC: 13.06 M
T. Rowe Price Investment Management, Inc.: 8.42 M
BlackRock, Inc.: 5.82 M
Redmile Group, LLC: 5.02 M
VANGUARD GROUP INC: 4.89 M
Point72 Asset Management, L.P.: 4.82 M
105.03% of Immunome, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 95.81 M shares in the last 24 months. This purchase volume represents approximately $1.19 B in transactions.